Study: Cinnamon Reduced Fasting Plasma Glucose (FPG), BMI, and Waist Circumference
Cinnamon has been discovered as a new treatment option for Type II
Diabetes. Cinnamon is an ingredient of Gene-Eden-VIR, the natural antiviral
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
The devastating effects of Diabetes on the human body are well known and very
little is known about how to cure it. However, a new study done by Thames
Valley University of London has made a breakthrough finding by discovering the
beneficial effects of cinnamon on diabetes. The aim of the study was to
determine the blood glucose lowering effect of cinnamon on HbA1c, blood
pressure and lipid profiles in people with type-2 diabetes, a condition
characterized by high blood glucose levels caused by either a lack of insulin
or the body's inability to use insulin efficiently. Type 2 diabetes develops
most often in middle-aged and older adults but can appear in young people as
well. This form of the disease is often related to choices of diet and
lifestyle and can be controlled by diet.
For the purpose of the study, 58 type-2 diabetic patients including 25 males
and 33 females aged 54.9 +- 9.8, treated only with hypoglycaemic agents and
with an HbA1c more than 7 per cent were at random assigned to be given either
2 g of cinnamon or placebo daily for 12 weeks.
The results of the study revealed that in the group that consumed cinnamon,
the mean HbA1c was considerably decreased from 8.22% to 7.86% as compared to
the placebo group which was 8.55% to 8.68%. The Mean systolic and diastolic
blood pressure (SBP and DBP) were also considerably reduced after 12 weeks in
the group that took cinnamon from SBP: 132.6 to 129.2 mmHg and DBP: 85.2 to
80.2 mmHg as compared with the placebo group that was SBP: 134.5 to 134.9 mmHg
and DBP: 86.8 to 86.1 mmHg.
A noteworthy reduction in fasting plasma glucose (FPG), body mass index (BMI)
and waist circumference was noticed at week 12 compared to baseline in the
cinnamon group, but the changes were not major as compared to placebo group.
On the basis of the study, it was established that consuming 2g of cinnamon
for 12 weeks significantly reduces the HbA1c, SBP and DBP among badly
controlled type-2 diabetes patients. Cinnamon supplementation could be well
thought-out as an extra dietary supplement alternative to regulate blood
glucose and blood pressure levels along with conventional medications to treat
type 2 diabetes mellitus.
Keeping in mind the aforesaid benefits of cinnamon and to ensure an easy and
daily intake of cinnamon, polyDNA developed Gene-Eden-VIR, an anti-viral
dietary supplement that is based on broad research and consists of proven
natural ingredients with strong anti-viral properties to fight against most of
the viruses and a variety of fatal diseases. Besides other carefully selected
ingredients, Gene-Eden-VIR is a rich source of Cinnamon and is an excellent
supplement to include in daily routine. This is a scientifically developed
and tested natural formula based of extensive research and analysis. It boosts
the immune system against latent viruses.
Gene-Eden-VIR can be bought exclusively on the Gene Eden website. To order,
visit the Gene-Eden-VIR
1. Directory on Type 2 Diabetes - Google List Service
2. Gene-Eden Website
3. Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in
multi-ethnic Type 2 diabetic patients in the UK: a randomized,
placebo-controlled, double-blind clinical trial. Diabet Med. 2010
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.